Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

OSIMERTINIB for Ill-defined disorder: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 35 adverse event reports in the FDA FAERS database where OSIMERTINIB was used for Ill-defined disorder.

Most Reported Side Effects for OSIMERTINIB

Side Effect Reports % Deaths Hosp.
Death 10,423 37.6% 10,418 239
Malignant neoplasm progression 2,920 10.5% 574 354
Diarrhoea 1,408 5.1% 174 431
Drug resistance 1,026 3.7% 139 98
Fatigue 819 3.0% 102 231
Rash 772 2.8% 79 212
Decreased appetite 706 2.5% 138 273
Drug ineffective 627 2.3% 144 111
Dyspnoea 621 2.2% 158 327
Nausea 610 2.2% 82 228
Disease progression 607 2.2% 107 33
Off label use 576 2.1% 115 124
Interstitial lung disease 573 2.1% 221 305
Metastases to central nervous system 560 2.0% 125 109
Myelosuppression 510 1.8% 10 166

Other Indications for OSIMERTINIB

Non-small cell lung cancer (6,358) Lung neoplasm malignant (4,754) Lung carcinoma cell type unspecified stage 0 (1,950) Non-small cell lung cancer metastatic (1,056) Lung adenocarcinoma (936) Egfr gene mutation (695) Product used for unknown indication (408) Non-small cell lung cancer stage iv (404) Neoplasm malignant (345) Lung carcinoma cell type unspecified stage iv (330)

Other Drugs Used for Ill-defined disorder

IBUPROFEN (707) ATORVASTATIN (570) DAPAGLIFLOZIN (556) SERTRALINE (437) AMLODIPINE (415) ROSUVASTATIN (361) OMEPRAZOLE (272) DOXYCYCLINE (254) PREGABALIN (248) LANSOPRAZOLE (227)

Related Pages

OSIMERTINIB Full Profile All Ill-defined disorder Drugs OSIMERTINIB Demographics OSIMERTINIB Timeline